Aug 26, 2015 8:30 am EDT Cryoport Supports Opexa Therapeutics' Lead Personalized T-Cell Immunotherapy Programs
Aug 06, 2015 8:00 am EDT Cryoport Reports 53% Revenue Growth for the First Quarter of Fiscal Year 2016
Jul 27, 2015 8:30 am EDT Cryoport's Portfolio of Temperature-Managed Clinical Programs Expands to 45 Trials
Jul 23, 2015 8:41 pm EDT Cryoport Announces Pricing of Public Offering of Units and Listing on NASDAQ
Jul 14, 2015 8:30 am EDT ZenBio Engages Cryoport to Support Distribution of its Human Cell-Based Products
Jun 17, 2015 8:30 am EDT Cryoport Selected for Logistics Support of CaRE Arthritis Personalized Medicine Efforts